High prevalence of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: A long-term prospective study using dynamic endocrine testing

World Neurosurgery

Volumn 83, Issue 4, 2015, Pages 574-582

  Kronvall, Erik ^a   Valdemarsson, Stig ^a   Säveland, Hans ^a   Nilsson, Ola G ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Growth hormone deficiency; Hypopituitarism; Outcome; Pituitary deficiency; Subarachnoid hemorrhage

Indexed keywords

ARGININE; CORTICOTROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PROLACTIN; VASOPRESSIN; HUMAN GROWTH HORMONE;

ADRENAL DISEASE; ADRENOCORTICOTROPIC HORMONE STIMULATION TEST; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION; ENDOCRINE FUNCTION TEST; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH HORMONE RELEASING HORMONE ARGININE STIMULATION TEST; HUMAN; HYPOADRENALISM; HYPOPHYSIS FUNCTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; NEUROHYPOPHYSIS DISEASE; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; BLOOD; COMPLICATION; GLUCOSE TOLERANCE TEST; MIDDLE AGED; PITUITARY DISEASES; PROCEDURES; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PITUITARY DISEASES; PITUITARY FUNCTION TESTS; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84930926687     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2014.12.007     Document Type: Review

References (27)

1. Aimaretti G, Ambrosio MR, Di Somma C, Gasperi M, Cannavo S, Scaroni C, Fusco A, del Monte P, deMenis E, Faustini-FustiniM, Grimaldi F, Logoluso F, Razzore P, Rovere S, Benvenga S, Degli Uberti EC, de Marinis L, Lombardi G, Mantero F, Martino E, Giordano G, Ghigo E: Residual pituitary function after brain injury-induced hypopituitarism: A prospective 12-month study. J Clin Endocrinol Metab 90:6085-6092, 2005.
2. Bendel S, Koivisto T, Ruokonen E, Rinne J, Romppanen J, Vauhkonen I, Kiviniemi V, Uusaro A: Pituitary-adrenal function in patients with acute subarachnoid haemorrhage: A prospective cohort study. Crit Care 12:R126, 2008.
3. Brandt L, Säveland H, Valdemarsson S, Sjöholm H, Reinstrup P: Fatigue after aneurysmal subarachnoid hemorrhage evaluated by pituitary function and 3D-CBF. Acta Neurol Scand 109: 91-96, 2004.
4. Bülow B, Hagmar L, Ørbaek P, Österberg K, Erfurth EM: High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease. Clin Endocrinol (Oxf) 56:183-193, 2002.
5. Courtney CH, McAllister AS, McCance DR, Bell PM, Hadden DR, Leslie H, Sheridan B, Atkinson AB: Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis. Clin Endocrinol (Oxf) 53:431-436, 2000.
6. Dimopoulou I, Kouyialis AT, Tzanella M, Armaganidis A, Thalassinos N, Sakas DE, Tsagarakis S: High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage. Stroke 35:2884-2889, 2004.
7. Finucane FM, Liew A, Thornton E, Rogers B, Tormey W, Agha A: Clinical insights into the safety and utility of the insulin tolerance test (ITT) in the assessment of the hypothalamo-pituitaryadrenal axis. Clin Endocrinol (Oxf) 69:603-607, 2008.
8. Gardner CJ, Javadpour M, Stoneley C, Purthuran M, Biswas S, Daousi C, Macfarlane IA, Cuthbertson DJ: Low prevalence of hypopituitarism after subarachnoid haemorrhage using confirmatory testing and with BMI-specific growth hormone cut-off levels. Eur J Endocrinol 168:473-481, 2013.
9. Grossman AB: The diagnosis and management of central hypoadrenalism [clinical review]. J Clin Endocrinol Metab 95:4855-4863, 2010.
10. Ho KKY: Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: A statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157:695-700, 2007.
11. Hütter BO, Gilsbach JM, Mayberg MR, Day AL: Which neuropsychological deficits are hidden behind a good outcome (Glasgow = I) after aneurysmal subarachnoid hemorrhage? Neurosurgery 33:999-1006, 1993.
12. Jennett B, Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1: 480-484, 1975.
13. Karaca Z, Tanriverdi F, Dagli AT, Selcuklu A, Casanueva FF, Unluhizarci K, Kelestimur F: Three years prospective investigation of pituitary functions following subarachnoid haemorrhage. Pituitary 16:76-82, 20y12.
14. Kelly DF, Gonzalo ITG, Cohan P, Berman N, Swerdloff R, Wang C: Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: A preliminary report. J Neurosurg 93:743-752, 2000.
15. Klose M, Brennum J, Poulsgaard L, Kosteljanetz M, Wagner A, Feldt-Rasmussen U: Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage. Clin Endocrinol (Oxf) 73:95-101, 2010.
16. Kreitschmann-Andermahr I, Hoff C, Saller B, Niggemeier S, Pruemper S, Hutter BO, Rohde V, Gressner A, Matern S, Gilsbach JM: Prevalence of pituitary deficiency in patients after aneurysmal subarachnoid hemorrhage. J Clin Endocrinol Metab 89:4986-4992, 2004.
17. Kronvall E, Valdemarsson S, Säveland H, Nilsson OG: Pituitary dysfunction after aneurysmal subarachnoid hemorrhage is associated with impaired early outcome. World Neurosurg 81:529-537, 2014.
18. Lammert A, Bode H, Hammes HP, Birck R, Fatar M, Zohsel K, Braun J, Schmieder K, Diepers M, Schubert GA, Barth M, Thome C, Seiz M: Neuro-endocrine and neuropsychological outcome after aneurysmal subarachnoid hemorrhage (ASAH): A prospective cohort study. Exp Clin Endocrinol Diab 119:111-116, 2011.
19. Nieuwkamp DJ, de Wilde A, Wermer MJ, Algra A, Rinkel GJ: Long-term outcome after aneurysmal subarachnoid hemorrhage-risks of vascular events, death from cancer and all-cause death. J Neurol 261:309-315, 2014.
20. Powell J, Kitchen N, Heslin J, Greenwood R: Psychosocial outcomes at 18 months after good neurological recovery from aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 72:119-124, 2004.
21. Rosén T, Bengtsson BA: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288, 1990.
22. Rosén T, Wirén L, Wilhelmsen L, Wiklund I, Bengtsson BA: Decreased psychological wellbeing in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf) 40:111-116, 1994.
23. Scharbrodt W, Stein M, Schreiber V, Boker DK, Oertel MF: The prediction of long-term outcome after subarachnoid hemorrhage as measured by the Short Form-36 Health Survey. J Clin Neurosci 16:1409-1413, 2009.
24. Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A: Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: A systematic review. JAMA 298:1429-1438, 2007.
25. Schuiling WJ, Rinkel GJ, Walchenbach R, de Weerd AW: Disorders of sleep and wake in patients after subarachnoid hemorrhage. Stroke 36:578-582, 2005.
26. Tanriverdi F, Dagli AT, Karaca Z, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F: High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: A prospective investigation of anterior pituitary function in the acute phase and 12 months after the event. Clin Endocrinol (Oxf) 67:931-937, 2007.
27. Visser-Meily JMA, Rhebergen ML, Rinkel GJE, van Zandvoort MJ, Post MWM: Long-term health-related quality of life after aneurysmal subarachnoid hemorrhage relationship with psychological symptoms and personality characteristics. Stroke 40:1526-1529, 2009.